“Medical Nutrition Market: Global Industry Analysis (2012-2016) and Forecast 2017-2025”, A new report by Persistence Market Research focuses on the parenteral nutrition segment and its overall performance in the global medical nutrition market for an eight-year period. The report segments the global parenteral medical nutrition market based on product type, distribution channel, nutrition type, and region.
This segment is divided into amino acid solution, multiple vitamins and antioxidants, lipid emulsion, trace elements, 2K sachets and 3K sachets. The amino acid solution segment dominated the global parenteral medical nutrition market in terms of revenue in 2016, and the trend is expected to increase throughout the forecast period. The Amino Acid Solution segment is the most attractive segment with a Market Attractiveness Index of 1.8 during the forecast period.
Get a sample copy of it [email protected] https://www.persistencemarketresearch.com/samples/16588
Hospital pharmacies, retail pharmacies, network pharmacies are the sub-segments of this category. The retail pharmacy segment is projected to be the second most lucrative market in the global parenteral nutrition market by distribution channel, with an attractiveness index of 0.5 during the forecast period. The retail pharmacies segment is estimated to have a value share of 13.1% in 2017. Hospital pharmacies will hold the largest market share with more than 65% throughout the forecast period.
Company Profiles:
- allergy
- Baxter International Inc.
- Braun Melsungen AG.
- Fresenius Kabi AG
- Pfizer, Inc.
- Sanofi
- Met Johnson & Company, LLC
- Sichuan Kelun Pharmaceutical Company Limited
- Otsuka Pharmaceuticals Co.,Ltd.
- Grifols SA
- Abbott Laboratories
- Danone Nutricia
- Demo SA Pharmaceutical Industry
- Other.
Request for [email protected] https://www.persistencemarketresearch.com/methodology/16588
The global parenteral medical nutrition market is being…
source_link https://www.digitaljournal.com/pr/the-advanced-medical-nutrition-market-to-atone-to-growth-in-the-next-10-years